Subject(s)
Carcinoma, Merkel Cell/etiology , Merkel cell polyomavirus/isolation & purification , Polyomavirus Infections/etiology , Skin Neoplasms/etiology , Ultraviolet Rays/adverse effects , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/epidemiology , Carcinoma, Merkel Cell/pathology , Female , Humans , Incidence , Male , New Zealand/epidemiology , Polyomavirus Infections/epidemiology , Polyomavirus Infections/pathology , Skin/pathology , Skin/radiation effects , Skin Neoplasms/epidemiology , Skin Neoplasms/pathologyABSTRACT
Antiphospholipid antibodies, a maternal risk factor for preeclampsia, increase shedding of necrotic trophoblast debris from the placenta, leading to endothelial dysfunction. Using Affymetrix HGU133 Plus 2 microarrays we found changes in the transcriptome of placental explants treated with antiphospholipid antibodies, including mRNAs BCL2L1, MCL1, PDCD2L, FASLG, SEMA6A, PRKCE and TRAIL that are involved in the regulation of apoptosis. Quantitative real-time RT-PCR and immunohistochemistry confirmed a reduction in TRAIL expression in response to antiphospholipid antibodies. These results may help to understand how antiphospholipid antibodies affect trophoblast cell death and how the antibodies could contribute to the pathogenesis of preeclampsia.
Subject(s)
Antibodies, Antiphospholipid/immunology , Pre-Eclampsia/immunology , TNF-Related Apoptosis-Inducing Ligand/metabolism , Trophoblasts/immunology , Trophoblasts/pathology , Antibodies, Antiphospholipid/metabolism , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Cells, Cultured , Female , Gene Expression Profiling , Gene Expression Regulation/immunology , Humans , Immunohistochemistry , Microarray Analysis , Necrosis/immunology , Pregnancy , TNF-Related Apoptosis-Inducing Ligand/geneticsABSTRACT
BACKGROUND: The non-malignant cells of the tumour stroma have a critical role in tumour biology. Studies dissecting the interplay between cancer cells and stromal cells are required to further our understanding of tumour progression and methods of intervention. For proof-of-principle of a multi-modal approach to dissect the differential effects of treatment on cancer cells and stromal cells, we analysed the effects of the stromal-targeting agent 5,6-dimethylxanthenone-4-acetic acid on melanoma xenografts. METHODS: Flow cytometry and multi-colour immunofluorescence staining was used to analyse leukocyte numbers in xenografts. Murine-specific and human-specific multiplex cytokine panels were used to quantitate cytokines produced by stromal and melanoma cells, respectively. Human and mouse Affymetrix microarrays were used to separately identify melanoma cell-specific and stromal cell-specific gene expression. RESULTS: 5,6-Dimethylxanthenone-4-acetic acid activated pro-inflammatory signalling pathways and cytokine expression from both stromal and cancer cells, leading to neutrophil accumulation and haemorrhagic necrosis and a delay in tumour re-growth of 26 days in A375 melanoma xenografts. CONCLUSION: 5,6-Dimethylxanthenone-4-acetic acid and related analogues may potentially have utility in the treatment of melanoma. The experimental platform used allowed distinction between cancer cells and stromal cells and can be applied to investigate other tumour models and anti-cancer agents.
Subject(s)
Antineoplastic Agents/pharmacology , Cytokines/metabolism , Melanoma/pathology , Xanthones/pharmacology , Animals , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cytokines/genetics , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Knockout Techniques , Gene Regulatory Networks , Homeodomain Proteins/genetics , Humans , Leukocytes/drug effects , Leukocytes/immunology , Macrophages/drug effects , Macrophages/immunology , Melanoma/drug therapy , Melanoma/immunology , Melanoma/metabolism , Mice , Mice, Knockout , Mice, Nude , Oligonucleotide Array Sequence Analysis , Stromal Cells/drug effects , Stromal Cells/metabolism , Transcription, Genetic , Tumor Burden/drug effects , Up-Regulation , Xanthones/therapeutic use , Xenograft Model Antitumor AssaysABSTRACT
MOTIVATION: Biological assays are often carried out on tissues that contain many cell lineages and active pathways. Microarray data produced using such material therefore reflect superimpositions of biological processes. Analysing such data for shared gene function by means of well-matched assays may help to provide a better focus on specific cell types and processes. The identification of genes that behave similarly in different biological systems also has the potential to reveal new insights into preserved biological mechanisms. RESULTS: In this article, we propose a hierarchical Bayesian model allowing integrated analysis of several microarray data sets for shared gene function. Each gene is associated with an indicator variable that selects whether binary class labels are predicted from expression values or by a classifier which is common to all genes. Each indicator selects the component models for all involved data sets simultaneously. A quantitative measure of shared gene function is obtained by inferring a probability measure over these indicators. Through experiments on synthetic data, we illustrate potential advantages of this Bayesian approach over a standard method. A shared analysis of matched microarray experiments covering (a) a cycle of mouse mammary gland development and (b) the process of in vitro endothelial cell apoptosis is proposed as a biological gold standard. Several useful sanity checks are introduced during data analysis, and we confirm the prior biological belief that shared apoptosis events occur in both systems. We conclude that a Bayesian analysis for shared gene function has the potential to reveal new biological insights, unobtainable by other means. AVAILABILITY: An online supplement and MatLab code are available at http://www.sykacek.net/research.html#mcabf
Subject(s)
Gene Expression Profiling/methods , Gene Expression/physiology , Models, Biological , Models, Statistical , Oligonucleotide Array Sequence Analysis/methods , Proteome/metabolism , Signal Transduction/physiology , Bayes Theorem , Computer Simulation , Data Interpretation, StatisticalABSTRACT
The aim of this study is to develop an overview of genetic events during spermatogenesis using a novel, specifically targeted gonadal gene set. Two subtracted cDNA libraries enriched for testis specific and germ cell specific genes were constructed, characterized and sequenced. The combined libraries contain >1905 different genes, the vast majority previously uncharacterized in testis. cDNA microarray analysis of the first wave of murine spermatogenesis and of selected germ cell-deficient models was used to correlate the expression of groups of genes with the appearance of defined germ cell types, suggesting their cellular expression patterns within the testis. Real-time RT-PCR and comparison to previously known expression patterns confirmed the array-derived transcription profiles of 65 different genes, thus establishing high confidence in the profiles of the uncharacterized genes investigated in this study. A total of 1748 out of 1905 genes showed significant change during the first spermatogenic wave, demonstrating the successful targeting of the libraries to this process. These findings highlight unknown genes likely to be important in germ cell production, and demonstrate the utility of these libraries in further studies. Transcriptional analysis of well-characterized mouse models of infertility will allow us to address the causes and progression of the pathology in related human infertility phenotypes.
Subject(s)
Gene Expression , Infertility, Male/genetics , Testis/metabolism , Animals , Gene Expression Profiling , Gene Library , Male , Mice , Models, Genetic , Multigene Family , Oligonucleotide Array Sequence Analysis , Testis/growth & developmentABSTRACT
Administration of RU486 in vivo during the receptive phase rapidly renders the endometrium non-receptive to the implanting embryo. In order to identify key pathways responsible for endometrial receptivity we have used cDNA arrays to monitor gene expression changes in short-term endometrial explants in response to RU486. Endometrial biopsies from five normal fertile women at mid-secretory phase were cultured in the presence of estradiol and progesterone with or without RU486 for 12 h. cDNA arrays were produced containing approximately 1000 sequence-verified clones which included genes known to be important in angiogenesis, apoptosis, cell signalling, extracellular matrix remodelling and cell cycle regulation. cDNA probes from the paired endometrial samples were hybridized to the arrays and hybridization signals were quantified. A total of 12 genes displayed significant changes in expression; six were up-regulated and six down-regulated following RU486 treatment. For five of these genes this is the first report suggesting that they are regulated by steroids in the endometrium. JAK1 and JNK1 were two of the genes shown by the arrays to be down-regulated in RU486-treated endometrial explants. This was confirmed by real time RT-PCR. JAK1 immunoreactivity was localized to both glandular epithelium and the stroma of normal endometrium and staining was much stronger in the luteal phase of the cycle. These results show that components of two important signalling pathways in endometrium-the JAK/STAT pathway, and the JNK pathway-are altered by RU486. Genes whose expression is controlled by these pathways are likely to be involved in the mechanism by which steroids render the endometrium receptive to the implanting embryo.
Subject(s)
Endometrium/physiology , Gene Expression Profiling , Gene Expression Regulation/drug effects , Luteolytic Agents/pharmacology , Mifepristone/pharmacology , Adult , Culture Techniques , Endometrium/cytology , Endometrium/drug effects , Endometrium/metabolism , Female , Humans , Janus Kinase 1 , Menstrual Cycle , Oligonucleotide Array Sequence Analysis , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolismABSTRACT
Anti-apoptotic members of the Bcl-2 family, such as Bcl-w, maintain cell viability by preventing the activation of the cell death effectors, the caspases. Gene targeting experiments in mice have demonstrated that Bcl-w is required for spermatogenesis and for survival of damaged epithelial cells in the gut. Bcl-w is, however, dispensable for physiological cell death in other tissues. Here we report on the analysis of Bcl-w protein expression using a panel of novel monoclonal antibodies. Bcl-w is found in a diverse range of tissues including colon, brain and testes. A survey of transformed cell lines and purified hematopoietic cells demonstrated that Bcl-w is expressed in cells of myeloid, lymphoid and epithelial origin. Subcellular fractionation and confocal laser scanning microscopy demonstrated that Bcl-w protein is associated with intracellular membranes. The implications of these results are discussed in the context of the phenotype of Bcl-w-null mice and recent data that suggest that Bcl-w may play a role in colon carcinogenesis.
Subject(s)
Gene Expression Profiling , Proteins/metabolism , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Apoptosis Regulatory Proteins , Blotting, Western , Cell Line , Fluorescent Antibody Technique , Humans , Hybridomas/cytology , Hybridomas/immunology , Intracellular Membranes/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Precipitin Tests , Protein Transport , Proteins/genetics , Proteins/immunology , Proto-Oncogene Proteins c-bcl-2 , Rats , Rats, Wistar , TransfectionABSTRACT
Expression of bcl-w, a close relative of bcl-2 is essential for male fertility in mice. Although the initial wave of spermatogenesis in bcl-w -/- mice proceeds normally until 3-4 weeks of age, adults fail to produce sperm. To clarify why bcl-w is essential for adult but not juvenile spermatogenesis, we investigated the expression pattern of eight bcl-2 family members. We found that both the level and pattern of expression varied in different cell types during juvenile and adult spermatogenesis. Anti-apoptotic genes bcl-w, bcl-2 and bcl-xL were all expressed in spermatogonia during juvenile spermatogenesis, but only bcl-w was detected in spermatogonia of adult mice. A similar shift was evident in Sertoli cells. This developmental regulation may co-ordinate physiological germ cell apoptosis in wild type mice and account for the time of onset for pathological germ cell apoptosis in bcl-w -/- animals.
Subject(s)
Proteins/physiology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Spermatogenesis/physiology , Testis/metabolism , Animals , Apoptosis Regulatory Proteins , Gene Expression Regulation, Developmental , In Situ Hybridization , Male , Mice , Mice, Inbred C57BL , Proteins/genetics , Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Sertoli Cells/metabolism , Spermatogonia/cytology , Spermatogonia/growth & development , Spermatogonia/metabolism , Testis/growth & development , bcl-X Protein/biosynthesis , bcl-X Protein/geneticsABSTRACT
The potential role of the bcl-2 relative bcl-w as a physiological regulator of apoptosis in intestinal epithelia has been investigated. Immunoblots for bcl-w with new monoclonal antibodies revealed that it was expressed in the small intestine and colon, among other murine tissues, as well as in six human tumour cell lines of epithelial origin, including two colon carcinoma lines. To assess whether bcl-w regulates either spontaneous or damage-induced apoptosis in the small intestine or colon, apoptosis in intestinal crypts of bcl-w -/- and wild-type mice was quantified microscopically on a cell positional basis. Spontaneous apoptosis within crypt epithelia was not significantly increased by loss of bcl-w, in either the small intestine or midcolon. However, after treatment with the cytotoxic drug 5-fluorouracil or with gamma-radiation, the bcl-w-null animals exhibited substantially more apoptosis than their wild-type counterparts in both tissues. The greatest enhancement of apoptosis attributable to the absence of bcl-w (up to sixfold) occurred in the small intestine. Hence, bcl-w is an important determinant of damage-induced apoptosis in intestinal epithelia, and unlike bcl-2, which regulates only colonic apoptosis, plays a major role in small intestinal epithelium.
Subject(s)
Apoptosis/physiology , Intestine, Large/pathology , Intestine, Small/pathology , Proteins/metabolism , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Apoptosis Regulatory Proteins , Carcinoma/metabolism , Carcinoma/pathology , Epithelial Cells/drug effects , Epithelial Cells/pathology , Epithelial Cells/radiation effects , Fluorouracil/pharmacology , Gamma Rays , Humans , Intestine, Large/drug effects , Intestine, Large/radiation effects , Intestine, Small/drug effects , Intestine, Small/radiation effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Tumor Cells, CulturedABSTRACT
Proapoptotic Bcl-2 family members activate cell death by neutralizing their anti-apoptotic relatives, which in turn maintain cell viability by regulating the activation of the cell death effectors, the caspases. Bim belongs to a distinct subgroup of proapoptotic proteins that only resemble other Bcl-2 family members within the short BH3 domain. Gene targeting experiments in mice have shown that Bim is essential for the execution of some but not all apoptotic stimuli, for hematopoietic cell homeostasis, and as a barrier against autoimmunity. There are three Bim isoforms, Bim(S), Bim(L), and Bim(EL), which have different proapoptotic potencies due at least in part to differences in interaction with the dynein motor complex. The expression pattern of Bim was investigated by immunohistochemical staining, immunoprecipitation followed by Western blotting, and in situ hybridization. Bim was found in hematopoietic, epithelial, neuronal, and germ cells. Bim(L) and Bim(EL) were coexpressed at similar levels in many cell types, but Bim(S) was not detected. Microscopic examination revealed a punctate pattern of Bim(L) and Bim(EL) immunostaining, indicating association with cytoplasmic structures. These results are discussed in the context of the phenotype of Bim-deficient mice and the post-translational regulation of Bim's pro-apoptotic activity.
Subject(s)
Carrier Proteins/metabolism , Epithelial Cells/metabolism , Germ Cells/metabolism , Hematopoietic Stem Cells/metabolism , Membrane Proteins , Neurons/metabolism , Proto-Oncogene Proteins , 3T3 Cells , Animals , Apoptosis , Apoptosis Regulatory Proteins , Bcl-2-Like Protein 11 , Blotting, Western , Cardiovascular System/metabolism , Carrier Proteins/genetics , Cell Line , Central Nervous System/metabolism , Digestive System/metabolism , Endocrine System/metabolism , Epithelial Cells/cytology , Female , Genitalia/metabolism , Germ Cells/cytology , HeLa Cells , Hematopoietic Stem Cells/cytology , Humans , Immunohistochemistry , In Situ Hybridization , Kidney/metabolism , Male , Mice , Mice, Inbred C57BL , Muscle, Skeletal/metabolism , Neurons/cytology , Rats , Rats, Wistar , Respiratory System/metabolism , Skin/metabolism , Tissue Distribution , Tumor Cells, CulturedABSTRACT
Mature sperm are the product of a precisely regulated developmental sequence in which germ cell proliferation, differentiation, self-renewal and apoptosis are carefully controlled. The control of germ cell apoptosis during spermatogenesis is especially important. It is mediated by signals derived from the Sertoli cells with which each germ cell is closely associated, as well as by signals originating outside the testis. A greater understanding of these signals is emerging from studies of the spermatogenic defects of genetically modified animals. In particular, the intracellular signaling cascades which ultimately determine germ cell fate are being illuminated by recent studies of the Bcl-2 protein family. This review summarises the crucial role which stringently regulated apoptosis plays in the production of male gametes.
Subject(s)
Apoptosis , Spermatogenesis/physiology , Spermatozoa/cytology , Animals , Cell Division , Cell Survival , Hormones/metabolism , Humans , Intracellular Fluid , Male , Paracrine CommunicationABSTRACT
Bcl-2, which can both reduce apoptosis and retard cell cycle entry, is thought to have important roles in hematopoiesis. To evaluate the impact of its ubiquitous overexpression within this system, we targeted expression of the human bcl-2 gene in mice by using the promoter of the vav gene, which is active throughout this compartment but rarely outside it. The vav-bcl-2 transgene was expressed in essentially all nucleated cells of hematopoietic tissues but not notably in nonhematopoietic tissues. Presumably because of enhanced cell survival, the mice displayed increases in myeloid cells as well as a marked elevation in B and T lymphocytes. The spleen was enlarged and the lymphoid follicles expanded. Although total thymic cellularity was normal, T cell development was altered: cells at the very immature and most mature stages were increased, whereas those at the intermediate stage were decreased. Unexpectedly, blood platelets were reduced by half, suggesting that their production from megakaryocytes is regulated by the Bcl-2 family. Colony formation by myeloid progenitor cells in vitro remained cytokine dependent, and the frequency of most progenitor and preprogenitor cells was normal. Macrophage progenitors were less frequent and yielded smaller colonies, however, perhaps reflecting inhibitory effects of Bcl-2 on cell cycling in specific lineages. After irradiation or factor deprivation, Bcl-2 markedly enhanced clonogenic survival of all tested progenitor and preprogenitor cells. Thus, Bcl-2 has multiple effects on the hematopoietic system. These mice should help to further clarify the role of apoptosis in the development and homeostasis of this compartment.
Subject(s)
Cell Cycle Proteins , Hematopoiesis/genetics , Hematopoietic Stem Cells/cytology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Animals , Cell Lineage , Cell Survival , Cells, Cultured , Cytokines/deficiency , Gamma Rays , Hematopoiesis/radiation effects , Hematopoietic Stem Cells/radiation effects , Humans , Mice , Mice, Transgenic , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-vav , Spleen/pathology , T-Lymphocytes/cytology , Thymus Gland/cytology , Tissue DistributionSubject(s)
Apoptosis/physiology , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Membrane Proteins , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins , Animals , Apoptosis Regulatory Proteins , Bcl-2-Like Protein 11 , Carrier Proteins/metabolism , Cell Survival/physiology , Homeostasis , Humans , Interphase/physiology , Leukocytes/cytology , Leukocytes/metabolism , Models, Biological , Signal TransductionABSTRACT
We have analyzed the effects of the alpha4 integrin ligands mucosal addressin cell adhesion molecule-1 (MAdCAM-1), vascular cell adhesion molecule-1 (VCAM-1), and the fibronectin CS-1 splice variant on T cell activation. Immobilized MAdCAM-1 and VCAM-1 IgG-Fc chimeras and a fibronectin CS-1 peptide efficiently costimulate T cell proliferation when antigen presentation is mimicked by anti-CD3 antibody. VCAM-1-Fc and fibronectin CS-1, which are adhesive ligands for both the alpha4beta1 and alpha4beta7 integrins, medicate T cell costimulation exclusively through integrin alpha4beta1, but not through alpha4beta7. The inability of VCAM-1-Fc to costimulate via alpha4beta7 suggests that cell adhesion per se is insufficient, and that exquisite recognition and activation events must be triggered. MAdCAM-1-Fc mediates costimulation exclusively via alpha4beta7, and can both synergize with and induce hyperresponsiveness to the classical costimulator B7-2. MAdCAM-1-Fc and VCAM-1-Fc, but not B7-2, effectively costimulate when immobilized on sites spatially distant from the anti-CD3 antibody ("remote" costimulation). In vitro, the relative potencies of the CAM were VCAM-1-Fc> ICAM-1-Fc> MAdCAM-1-Fc > B7-Fc, except at high concentrations where ICAM-1 was the most potent. Features of costimulatory CAM revealed by this study have important implications for the design of immunotherapeutic vaccine strategies to combat cancer and infection.
Subject(s)
Antigens, CD/physiology , B7-1 Antigen/physiology , Fibronectins/physiology , Immunoconjugates , Immunoglobulins/physiology , Lymphocyte Activation , Mucoproteins/physiology , T-Lymphocytes/immunology , Vascular Cell Adhesion Molecule-1/physiology , Abatacept , Adult , Amino Acid Sequence , Animals , Antigens, Differentiation/physiology , CTLA-4 Antigen , Cell Adhesion Molecules , Humans , Integrin alpha4 , Interleukin-2/metabolism , Mice , Molecular Sequence Data , RatsABSTRACT
Proteins of the Bcl-2 family are important regulators of apoptosis in many tissues of the embryo and adult. The recently isolated bcl-w gene encodes a pro-survival member of the Bcl-2 family, which is widely expressed. To explore its physiological role, we have inactivated the bcl-w gene in the mouse by homologous recombination. Mice that lack Bcl-w were viable, healthy, and normal in appearance. Most tissues exhibited typical histology, and hematopoiesis was unaffected, presumably due to redundant function with other pro-survival family members. Although female reproductive function was normal, the males were infertile. The testes developed normally, and the initial, prepubertal wave of spermatogenesis was largely unaffected. The seminiferous tubules of adult males, however, were disorganized, contained numerous apoptotic cells, and produced no mature sperm. Both Sertoli cells and germ cells of all types were reduced in number, the most mature germ cells being the most severely depleted. The bcl-w-/- mouse provides a unique model of failed spermatogenesis in the adult that may be relevant to some cases of human male sterility.
Subject(s)
Apoptosis/genetics , Proteins/physiology , Proto-Oncogene Proteins/physiology , Spermatogenesis/genetics , Animals , Apoptosis Regulatory Proteins , Embryonic and Fetal Development/genetics , Female , Hematopoiesis/genetics , Male , Mice , Mice, Inbred C57BL , Pregnancy , Proteins/genetics , Proto-Oncogene Proteins/genetics , Sexual Maturation , Spermatozoa/cytologyABSTRACT
The differentiation of myeloid cells into macrophages and granulocytes is accompanied by marked changes in adhesive phenotype. Here we seek to understand the regulation of expression and functionality of the VLA-4 (alpha 4 beta 1), LPAM-1 (alpha 4 beta 7) and HML-1 (alpha E beta 7) integrins on monocytes/macrophages and granulocytes, given that these integrins including LFA-1 (alpha L beta 2) mediate the entry, retention and signalling events of pathogenic leucocytes within chronically inflamed tissues. Phorbol ester-induced monocytic differentiation of the promyelocyte cell line HL60 led to increases in the steady-state levels of beta 2 and beta 7 mRNA transcripts, requiring a period of 10 and 24 h, respectively, of de novo protein synthesis. There was a parallel de novo expression of LPAM-1 on the cell surface, despite the fact that alpha 4 mRNA transcripts were rapidly down-regulated. At 72 h, HML-1 was not coexpressed with LPAM-1 on HL60 cells, although it was weakly expressed on peripheral blood monocytes/macrophages after a prolonged period of in vitro culture. Retinoic acid-induced granulocytic differentiation of HL60 cells led to the appearance of low levels of LPAM-1 at the cell surface. LPAM-1 was not found expressed on peripheral blood neutrophils, raising the possibility that it is transiently expressed during granulocyte differentiation. In accord with the above findings, differentiated monocytes and HL60 cells bound to recombinant MAdCAM-1 in an alpha 4- and beta 7-integrin-dependent fashion, whereas a population of undifferentiated HL60 cells and Mn(+2)-activated monocytes bound in an alpha 4-integrin-dependent beta 7-integrin-independent manner via VLA-4 expressed abundantly at all stages of differentiation. Four h after attachment, some of these VLA-4+ LPAM-1- HL60 cells could be seen to start spreading. These finding suggest that MAdCAM-1 can bind to VLA-4 when LPAM-1 is absent, and thus has the potential to recruit both VLA-4-bearing monocytes and VLA-4+ LPAM-1+ macrophages into chronically inflamed tissues.
Subject(s)
Immunoglobulins/metabolism , Integrin beta Chains , Integrins/metabolism , Mucoproteins/metabolism , Receptors, Lymphocyte Homing/metabolism , Antigens, CD/genetics , Antigens, CD/metabolism , CD18 Antigens/genetics , CD18 Antigens/metabolism , Cell Adhesion Molecules , Cell Differentiation , HL-60 Cells , Humans , Integrin alpha4 , Integrin alpha4beta1 , Integrins/genetics , Protein Biosynthesis , RNA, MessengerABSTRACT
The analysis of cDNA clones encoding novel variant forms of mouse kinectin, an endoplasmic reticulum (ER)-bound receptor for the motor protein kinesin, is reported. Kinesin and cytoplasmic dynein are involved in mediating the anterograde and retrograde movements of intracellular vesicles along the microtubule network. The amino acid sequence deduced from kinectin cDNA isolated from mouse spleen cell and testis libraries revealed a long signal peptide or transmembrane sequence, and a 328 amino acid residue globular N-terminal domain adjacent to a much larger 858-999-residue C-terminal coiled-coil rod domain. The C-terminal domain was composed of 18 coiled-coil regions formed from multiple contiguous heptad repeats which undergo alternative splicing as evidenced by the presence of at least five small (23-33 amino acid residue) insertion sequences scattered throughout. The inserts are present in any one of a number of combinations, generating an array of novel kinectin variants. Insert 5 contains a termination codon, producing a C-terminus that is highly homologous to that of human kinectin. Three out of five mouse kinectin clones lack insert 5, generating a novel eleven amino acid C-terminus encoded by sequence that extends past the insertion site. The existence of alternative C-termini may have functional relevance given that the C-termini are exposed for interaction with kinesin, whereas the globular N-terminus is embedded in the ER membrane. Alternative C-termini represent candidate modifications that could determine specificity of binding to kinesin or cytoplasmic dynein, and the switching of directionality of movement. The cDNA hybridized to 4.5 kb transcripts expressed in all mouse cell lines and tissues examined, which provides the first indication that the kinectins are very widely distributed. Mouse kinectin is 42% similar over a 203 amino acid region to the chicken extracellular cardiac morphogen ES/130, whose canine homologue containing an inserted sequence of 10 amino acids repeated 54 times in tandem, is a ribosome receptor expressed on the ER. Mouse kinectin shares 64 and 83% identity, respectively, with its M(r) 160000 chicken and human kinectin homologues. There is a two-fold molar excess of kinectin over kinesin in unextracted vesicles, suggesting that kinectin might be a dimer. The electrostatic properties of the coiled-coil region of mouse kinectin, together with the relative frequencies of residues in particular positions within the heptad repeats support this notion.
Subject(s)
Alternative Splicing , Avian Proteins , Evolution, Molecular , Membrane Proteins , Receptors, Cell Surface/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cloning, Molecular , DNA, Complementary , Extracellular Matrix Proteins/chemistry , Humans , Male , Mice , Molecular Sequence Data , Protein Folding , RNA, Messenger , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/classification , Sequence Homology, Amino Acid , Tissue DistributionABSTRACT
A novel antigen detected by the CBF.78 monoclonal antibody (MoAb) is strongly expressed on cortical thymocytes and weakly expressed on resting peripheral T lymphocytes. Expression of the antigen is increased on phytohemagglutinin (PHA)- and anti-CD3-activated T lymphocytes and on Epstein-Barr virus-transformed B lymphocytes. The CBF.78 immunoprecipitated a protein of 116 kD from resting and PHA-activated peripheral blood mononuclear cells. CBF.78 MoAb did not inhibit T-cell proliferation induced by anti-CD3 antibody. This MoAb was effective for immunostaining on paraffin sections after microwave-oven heating of tissue sections. Among malignant lymphomas, the antigen recognized by CBF.78 MoAb was found to be mainly expressed by T-cell lymphomas (49+ of 74), particularly those of high-grade malignancy (31+ of 36), whereas only occasional B-cell lymphomas (4+ of 107) expressed the antigen. A distinctive pattern of reactivity was shown by 108 cases of anaplastic large cell lymphomas. Strong positivity for CBF.78 antibody was observed in 86+ of 108 cases, irrespective of B, T, or null phenotype. This multicenter study suggests that CBF.78 MoAb could be of diagnostic value in differentiating Hodgkin's-like anaplastic large cell lymphomas from cases of Hodgkin's disease rich in neoplastic cells. Only a few cases of Hodgkin's disease (13+ of 126) showed rare Reed-Sternberg cells that stained, In these few cases, staining was weak to moderate and confined to cytoplasm. CBF.78 MoAb was nonreactive with all nonhematopoietic neoplasms examined (0+ of 48). Further studies should delineate the function of this new antigen and its clinical utility.
Subject(s)
Antibodies, Monoclonal , Antigens, Neoplasm/analysis , Hodgkin Disease/diagnosis , Lymphoma, Large B-Cell, Diffuse/diagnosis , Animals , Antibodies, Monoclonal/pharmacology , Diagnosis, Differential , Flow Cytometry , Hodgkin Disease/immunology , Humans , Immunoenzyme Techniques , Immunosorbent Techniques , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, T-Cell/immunology , Mice , Mice, Inbred BALB C , T-Lymphocytes/immunologyABSTRACT
MAdCAM-1 is a high endothelial venule adhesion molecule composed of immunoglobulin and mucin-like domains which binds the leucocyte integrin LPAM-1 (alpha 4 beta 7), and is largely responsible for the selective homing of lymphocytes to mucosal tissues. A novel soluble form of mouse MAdCAM-1 which is normally membrane bound has been produced by joining the extracellular region of the receptor to the Fc domain of human IgG1. The MAdCAM-1-Fc cDNA was inserted into the genome of Autographa californica nuclear polyhedrosis virus (AcNPV). Spodoptera frugiperda insect cells infected with the recombinant virus produced MAdCAM-1-Fc as a disulfide-linked homodimer of 82 kDa polypeptides, which was secreted into the culture medium at > 1 microgram/ml. The product purified by Protein G-Sepharose was identified as authentic MAdCAM-1-Fc by the anti-MAdCAM-1 monoclonal antibody (MoAb) MECA-367 using Western blot and ELISA analysis. When immobilized on glass it was fully functional in supporting the binding of mouse alpha 4 beta 1+ alpha 4 beta 7+ mesenteric lymph node lymphocytes, and the alpha 4 beta 1- alpha 4 beta 7+ TK1 T cell lymphoma. Binding was enhanced by Mn(++)-induced integrin activation, and specifically blocked by anti-integrin alpha 4 subunit and anti-MAdCAM-1 MoAbs. Binding was blocked by pretreatment of cells with sodium azide, and EDTA, indicating that binding is an energy-dependent process which requires divalent cations. Thus the mouse MAdCAM-1-Fc chimera produced in insect cells retains certain functional properties that typify the native receptor, and should be valuable in analysing the role of MAdCAM-1 in lymphocyte recirculation and emigration. However it was not sialylated despite being post-translational modified with N- and O-linked carbohydrate moieties, suggesting that the ability of MAdCAM-1 to support cell adhesion under static conditions is sialylation-independent. A rabbit polyclonal antibody raised against the entire cytoplasmic domain of the human integrin beta 7 subunit recognized LPAM-1-like molecules in human, rat, and mouse cells, suggesting a high degree of conservation of the MAdCAM-1 receptor across species. In agreement with this notion MAdCAM-1-Fc immobilized on glass was fully functional in supporting the cation-dependent binding of peripheral blood or spleen cells from a range of other species including human, rat, and guinea pig; and for human myeloid HL60 cells, binding was mediated by alpha 4 integrins.